Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk
- 1 January 2005
- journal article
- Published by Elsevier in Cancer Detection Prevention
- Vol. 29 (2) , 124-132
- https://doi.org/10.1016/j.cdp.2004.11.002
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- National Use of Postmenopausal Hormone TherapyJAMA, 2004
- Estrogen Replacement Therapy and Ovarian CancerEpidemiology, 2004
- Menopausal Hormone Replacement Therapy and Risk of Ovarian CancerJAMA, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Hormone Replacement Therapy and the Risk of Invasive Epithelial Ovarian Cancer in Swedish WomenJNCI Journal of the National Cancer Institute, 2002
- Estrogen Replacement Therapy and Ovarian Cancer Mortality in a Large Prospective Study of US WomenJAMA, 2001
- Developments in the pathology of ovarian tumoursCurrent Opinion in Obstetrics and Gynecology, 2001
- Differences in Risk Factors for Epithelial Ovarian Cancer by Histologic Type: Results of a Case-Control StudyAmerican Journal of Epidemiology, 1996
- Epithelial Ovarian Cancer and Combined Oral ContraceptivesInternational Journal of Epidemiology, 1989